INAB
IN8bio Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
IN8bio Inc is a biotechnology company focused on developing cancer treatments using genetically modified immune cells.
IN8bio Inc
INAB
IN8bio Inc is a biotechnology company focused on developing cancer treatments using genetically modified immune cells.
Price history of IN8bio Inc
Price history of IN8bio Inc
Performance & Momentum
Strategic Analysis
IN8bio Inc • 2026
IN8bio Inc positions itself in biotechnology by developing innovative cancer therapies based on the genetic modification of immune cells. Its model is focused on cutting-edge treatments aimed at harnessing the immune system to target tumors, which gives it a specialized technological niche in immuno-oncology.
- Specialization in innovative cell therapies with high scientific potential
- Strong focus on immuno-oncology, a growing and high-demand sector
- Expertise in genetic engineering applied to cancer treatment
- Severely degraded long-term stock performance, indicating significant risk
- Lack of recent positive news, limiting visibility on the pipeline and funding
Momentum is virtually nil, confirmed by a persistent downward trend over several years. This dynamic reflects significant operational or market challenges and suggests increased caution for investors, despite the innovative potential of the sector.
Similar stocks to IN8bio Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
